Catalent, Inc.
(NYSE : CTLT)

( )
CTLT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.26%165.190.7%$1305.30m
LLYEli Lilly & Co. 0.57%331.781.1%$1072.82m
ABBVAbbVie, Inc. 0.94%143.331.9%$877.03m
PFEPfizer Inc. -0.47%44.250.9%$815.29m
BMYBristol-Myers Squibb Co. 0.34%71.451.0%$767.68m
MRKMerck & Co., Inc. 0.01%88.400.7%$706.05m
AZNAstraZeneca Plc -0.54%56.731.0%$402.73m
ALNYAlnylam Pharmaceuticals, Inc. -0.11%201.028.2%$225.00m
GSKGSK Plc -1.01%30.400.3%$210.45m
NVSNovartis AG -1.11%77.360.2%$209.93m
IDXXIDEXX Laboratories, Inc. 0.44%350.123.9%$189.64m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$183.92m
HZNPHorizon Therapeutics Plc 1.35%67.055.4%$182.38m
NVONovo Nordisk A/S 0.63%106.040.1%$132.75m
SRPTSarepta Therapeutics, Inc. -0.76%110.6212.4%$132.70m

Company Profile

Catalent, Inc. is a holding company, which engages in the provision of delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. It operates through the following segments: Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment offers formulation, development, and manufacturing services for soft capsules or softgels, as well as large-scale production of oral solid dose forms for pharmaceutical and consumer health markets and supporting ancillary services. The Biologics segment develops and produces biologic cell-line, cell therapy, and viral vector gene therapy, formulation for parenteral dose forms, which include prefilled syringes, vials, and cartridges, and analytical development and testing services for large molecules. The Oral and Specialty Delivery segment is composed of advanced formulation of a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is involved in packaging, storage, distribution, and inventory management of drugs and biologics in clinical trials. The company was founded in 1933 and is headquartered in Somerset, NJ.